Necrotizing enterocolitis (NEC), a severe inflammation of the small intestine, is the most common and most lethal disease affecting the GI tract of the premature infant. Despite aggressive medical and surgical treatment, the mortality rate for NEC is typically 15%--30% in the very low birth weight neonates and approaches 100% in cases involving pan-necrosis [@bb0005], [@bb0010]. Unfortunately, the incidence of NEC continues to rise because recent advances in neonatology have resulted in the survival of infants born at 23 weeks gestation [@bb0015].

1. Pathogenesis of NEC {#s0005}
======================

According to the currently accepted pathogenetic scenario, perinatal insults such as hypoxia, hypothermia, and enteral feeding with formula compromise the barrier function of the intestinal epithelium [@bb0020]. At the same time, bacterial colonization of the neonate\'s GI tract occurs [@bb0025], [@bb0030], [@bb0370]. Some luminal bacteria and their components, such as lipopolysaccharide (LPS), CpG DNA, or flagellin, translocate across the compromised barrier and engage immunocytes, eliciting the production of inflammatory factors including proinflammatory cytokines, NO and peroxynitrite, and inflammatory prostanoids [@bb0035], [@bb0040], [@bb0045], [@bb0050], [@bb0055]. These proinflammatory stimuli damage the barrier by their effects on the epithelial tight junctions [@bb0060]. They also increase the rate of enterocyte cell death and decrease the rates of enterocyte proliferation and migration [@bb0065]. Increased barrier damage and decreased epithelial restitution further compromise the mucosal barrier, leading to more bacterial translocation, more inflammation, and more epithelial injury, which, if unchecked, may culminate in intestinal perforation, fulminant sepsis and death ([Fig. 1](#f0010){ref-type="fig"} ). Although this scenario is broadly accepted, the specific details at each step remain largely unknown. In this review we will examine the roles of inflammatory NO and opportunistic pathogens in the pathogenesis of NEC.Fig. 1Pathogenesis of NEC. Perinatal insults of prematurity including hypoxia, formula feeding, and colonization with opportunistic pathogens compromise the gut barrier, leading to bacterial translocation. After crossing the barrier, bacteria engage the innate immune cells of the lamina propria and elicit an inflammatory response by stimulating production of nitric oxide, inflammatory cytokines, and inflammatory prostanoids. These inflammatory factors further compromise the gut barrier, increasing bacterial translocation and exacerbating inflammation. A vicious circle of inflammation-inflicted barrier damage and bacterial translocation culminates in intestinal necrosis.

2. Role of nitric oxide {#s0010}
=======================

Nitric oxide is known to play a paradoxical role in intestinal physiology. NO is produced from arginine in a reaction catalyzed in the intestine mainly by two NO synthases (NOS), endothelial NOS or eNOS, and inducible NOS, or iNOS. eNOS is constitutively expressed in the intestinal microcapillaries at low levels and is responsible for the low background levels of NO. Low levels of NO regulate vascular tone and mucosal blood flow in a cyclic GMP- and neuron-dependent manner. Constitutively low production of NO is also required for the maintenance of mucosal capillaries [@bb0070] and mucosal homeostasis [@bb0075]. NO may protect from oxidative stress by scavenging oxygen radicals [@bb0080]. eNOS-derived NO promotes leukocyte adhesion to the endothelium, facilitating leukocyte recruitment [@bb0085]. These are all beneficial effects. iNOS is upregulated during inflammation and is responsible for high levels of NO, which dramatically increase blood flow by dilating the capillaries. Our lab was the first to demonstrate that sustained upregulation of iNOS in the intestine caused by LPS, can lead to gut barrier failure [@bb0055]. Indeed, high levels of NO seen during inflammation exert detrimental effects on the gut barrier leading to increased bacterial translocation [@bb0090], [@bb0095], impaired mitochondrial function [@bb0100] and epithelial restitution [@bb0105], as well as decreased leukocyte recruitment by the endothelium [@bb0110], [@bb0115]. NO readily reacts with the superoxide ion to form peroxynitrite, a reactive oxygen and nitrogen species that is highly toxic to epithelial cells [@bb0120]. Peroxynitrite may damage the epithelium in multiple ways. It may induce enterocyte apoptosis and inhibit epithelial restitution processes including enterocyte proliferation and migration [@bb0125], [@bb0130], [@bb0135]. We were the first to demonstrate increased expression of iNOS mRNA and protein in the intestinal mucosa during NEC [@bb0140]. iNOS upregulation is accompanied by increased rate of enterocyte apoptosis. The latter colocalizes with iNOS expression and nitrotyrosine immunoreactivity, a molecular footprint of peroxynitrite, in enterocytes. iNOS expression decreased at the time of stoma closure when the acute inflammation had subsided [@bb0120]. Thus, on the one hand NO plays an important role in intestinal homeostasis, but on the other hand, high levels of NO contribute to the epithelial damage seen in NEC.

3. Regulation of iNOS expression by bacteria {#s0015}
============================================

Regulation of the iNOS gene in response to bacteria and their pathogen-associated molecular patterns has been most extensively studied in macrophages and neutrophils, the specialized cells of the innate immune system, in the C57Bl/6 strain of mice. In these cells, iNOS is induced by pathogenic bacteria such as *Listeria monocytogenes*, or bacterial components such as LPS. This induction involves signaling via pattern recognition Toll-like receptors, activation of the transcription factor nuclear factor kappa B (NF-kB), binding of NF-kB to the iNOS promoter, and transcriptional induction of the iNOS gene [@bb0145], [@bb0150]. Toll-like receptor ligands alone cause only moderate induction of iNOS in macrophages; full-scale induction requires costimulation with type I or type II interferons [@bb0155]. These interferons are produced by natural killer cells and T cells in response to stimulation with Toll-like receptor ligands. Interferons act via their cognate receptors on macrophages to activate signal transduction activators of transcription (STATs) and interferon response factors (IRFs), which form transcription activation complexes on the iNOS promoter at distinct locations from NF-kB-binding sites [@bb0155]. Thus, efficient induction of iNOS in mouse macrophages requires synergy between macrophages and T cells, between Toll-like receptor ligands and interferons, and between distinct transcription activation complexes acting on the iNOS promoter.

Findings in C57Bl/6 mice may not be universally applicable. Macrophages from BALB/c mice produce much less iNOS upon stimulation with LPS and interferon compared to those from C57Bl/6 mice [@bb0160]. Numerous studies failed to detect iNOS induction in human macrophages/monocytes of various tissue origin upon stimulation ex vivo, although expression of iNOS was sometimes detected in macrophages isolated from patients with a variety of inflammatory disorders [@bb0165]. Similarly, little or no iNOS induction was observed in rat, bovine, or porcine macrophages [@bb0170], [@bb0175]. It has been suggested that stimuli other than LPS/interferon are required to induce iNOS in macrophages of species other than mice [@bb0180]. Indeed, induction of iNOS by *Leischmania* is strongly potentiated by IL-1β [@bb0185]. Differences in organization of the iNOS promoter between mice and other vertebrates [@bb0190] may reflect the roles of alternative transcription factors and signaling pathways.

Another possibility is that cell types other than macrophages could be sources of NO during NEC. iNOS expression is not confined to macrophages, it has been detected in a broad array of tissues and cell types [@bb0195]. Of interest to mucosal pathophysiology, iNOS is expressed in intestinal smooth muscle cells [@bb0200], [@bb0205], in endothelial cells of the intestinal capillaries [@bb0110], [@bb0115], and in enterocytes [@bb0210], [@bb0215]. Moreover, the epithelium is the major site of iNOS expression and NO production during intestinal inflammatory disorders [@bb0220], [@bb0225]. We have shown that experimental NEC induced by the opportunistic pathogen *Cronobacter muytjensii* in rats depends on the upregulation of intestinal iNOS [@bb0230]. Although the intestinal epithelium may be a major source of NO in the pathogenesis of NEC, the molecular mechanisms of mucosal iNOS induction in this disease remain unclear.

4. Microbiota in NEC {#s0020}
====================

Current evidence suggests that bacterial colonization of the gut is a key prerequisite for the pathogenesis of NEC. Indeed, germ-free rats [@bb0235] or mice [@bb0240] do not develop NEC. Over the last 20 years there have been numerous attempts to identify specific bacteria that contribute to the development of NEC. These studies compared bacterial populations found in patients with NEC to those found in healthy individuals. Although some studies reported an association between the prevalence of proteobacteria [@bb0245], [@bb0250], [@bb0255], [@bb0260], [@bb0265], [@bb0270], clostridia [@bb0275], staphylococci [@bb0280], or decreased bacterial species diversity [@bb0260], [@bb0270] with the development of NEC, other studies failed to corroborate these findings. The same bacterial species that were found in NEC patients were also found in healthy individuals [@bb0285], [@bb0290], [@bb0295], [@bb0300], [@bb0305]. These observations led some to conclude that NEC is not caused by any specific pathogen [@bb0310]. Thus, the question of whether NEC is associated with specific bacteria or specific patterns of microbiota remains unanswered.

5. Characteristics of early microbiota {#s0025}
======================================

Although studies of the neonatal gut microbiome failed to establish colonization patterns pertinent to NEC, they nevertheless revealed important differences between adult and early postnatal bacterial populations. Adult populations are very complex and feature more than one thousand species; they are relatively uniform, with the proportion of different groups and total bacterial load varying little among individuals. In addition, they are stable, with different groups of bacteria displaying little change over time [@bb0315], [@bb0320], [@bb0325], [@bb0330]. By contrast, early postnatal populations are very simple, featuring typically 1--5 species; they are highly diverse with regard to total bacterial load and species composition, and they are transient, with different groups of bacteria rapidly succeeding one another [@bb0030]. [Fig. 2](#f0015){ref-type="fig"} presents an example of interindividual diversity of the neonatal microbiota. In a litter of 4 day-old formula-fed rats, the total bacterial load and composition within each animal were quite different. The total bacterial load in animal 9 is almost 4 orders of magnitude higher than that in animal 4. In animals 1, 4, and 9 the predominant colonizer is *Shigella* spp., while in animals 2, 3, 5, 6, and 7 it is the bacterium S1-91. *Enterococcus faecalis* is the predominant colonizer in animal 8. Thus, even among littermates kept in the same environment, the initial bacterial population may be quite dissimilar (Bell BA, Ford HR, unpublished).Fig. 2An example of diverse early intestinal microbiota in a litter of rats. The neonates were separated at birth and formula-fed for 4 days. Equal samples of the small intestine were serially diluted and plated on blood agar. Following 2-day incubation at 37 °C, the emerging bacterial colonies were classified and enumerated. Bacterial species were determined by sequencing a variable region of the 16S rRNA gene. Each pie chart represents an individual littermate. Total loads of bacteria in cfu/ml are given below each pie chart.

From the results of multiple clinical studies, the most common first colonizers are not surprisingly normal human commensals from various bodily compartments, such as intestinal *Escherichia coli* and *Enterococcus*, skin *Staphylococcus*, oral cavity *Streptococcus*, or vaginal *Lactobacillus*. Less common commensals, including intestinal *Enterobacter*, *Shigella*, and *Salmonella*, or respiratory tract commensals such as *Haemophilus*, *Klebsiella*, or *Pseudomonas* are also found, although less frequently. Surprisingly, many species of bacteria from the environment -- bacteria from domestic animals, plants, soil, or water -- can also act as predominant first colonizers, although colonization with these species is relatively infrequent. Thus far, more than a hundred bacterial species have been identified as first colonizers, although this might be just the tip of the iceberg. It is apparent that a very broad array of bacteria is capable of colonizing the neonate\'s intestine [@bb0030].

6. Hospital outbreaks of NEC {#s0030}
============================

Although some believe that NEC is not caused by specific pathogens, the extensive body of evidence regarding hospital outbreaks of NEC argues that NEC may have an infectious etiology. NEC is not a very common disease, therefore whenever a cluster of similar cases occurs in a hospital environment, it is assumed that a common pathogen is involved. Although a causal relationship between a given pathogen and NEC has been rigorously proven only in a few cases, the putative pathogens were tentatively identified or suspected based on their presence in patients, but not in healthy subjects ([Table 1](#t0005){ref-type="table"} ). The conclusion from various hospital outbreaks is that the relationship between NEC and putative microbial pathogens is not as stringent as, for example, between cholera and *Vibrio cholera*. In fact, NEC can be caused by a broad variety of pathogens of bacterial, viral, or fungal origin [@bb0030], [@bb0335].Table 1Infectious agents associated with hospital cases of NEC.Gram^−^ bacteriaGram^+^ bacteriaVirusesFungi*Cronobacter muytjensiiEnterococcus faecalis*Cytomegalovirus*Candida* spp.*Pseudomonas aeruginosaStaphylococcus aureus*Rotavirus*Aspergillus* spp.*Klebsiella pneumoniaeStaphylococcus epidermidis*Adenovirus*Absidia* spp.*Enterobacter* spp.*Clostridium difficile*Coronavirus*Mucor* spp.*Escherichia coli* O157:H7*Clostridium perfringens*Echovirus 7*Salmonella* spp.*Clostridium butyricum*Torovirus*Shigella* spp.AstrovirusHerpesvirus

7. Identification of NEC pathogens {#s0035}
==================================

Clinical and experimental studies of NEC pathogens have been largely inconclusive because the ability of pathogenic microbes to cause NEC is rarely proven with rigor. To unambiguously identify a pathogen one has to satisfy Koch\'s three postulates. First, the microbe must be isolated from a diseased individual and grown in pure culture. Second, the ability of the isolated microbial strain to cause the disease must be proven by introduction into a healthy individual. Third, the microbe must be reisolated from the inoculated, diseased experimental host and confirmed to be identical to the originally isolated strain. All three postulates can be satisfied using animal models of NEC. So far, only a few strains of bacteria have been proven in this rigorous manner to be true NEC pathogens. They include strains of *Clostridium butyricum* and *Clostridium perfringens* [@bb0340], *Helicobacter hepaticus* MU 94-1 [@bb0345], and *C. muytjensii* 51329 [@bb0350].

8. Studies in *C. muytjensii* {#s0040}
=============================

One of the best studied opportunistic pathogens associated with NEC is *C. muytjensii*, previously known as *Enterobacter sakazakii* or *Cronobacter sakazakii*. This is a common food spoilage bacteria frequently found in dairy products, sometimes in baby formula. *C. muytjensii* has been identified as an opportunistic pathogen associated with multiple hospital outbreaks of meningitis, sepsis, and NEC in preterm neonates [@bb0355]. When live *C. muytjensii* 51329 was introduced in formula that was gavage-fed to neonatal rats, NEC scores significantly increased in these animals compared to neonates fed formula alone. One could argue that introduction of any bacteria regardless of the species could have the same effect. However, introduction of the same number of colony-forming units of a commensal strain of *E. coli* did not cause any appreciable change in histology scores. Therefore, the effect appears to depend on bacterial species [@bb0350]. Interestingly, *C. muytjensii* 51329 was found attached to the outer surface of the villus epithelium, suggesting that these bacteria are capable of binding enterocytes. *C. muytjensii* 51329 also dramatically increased the levels of enterocyte apoptosis. In the absence of bacteria, apoptosis was largely confined to the villus tips where the enterocytes are continuously shed. However, in the presence of *C. muytjensii* 51329, the apoptotic events were evenly spread over the surface of the villi [@bb0350]. Thus, *C. muytjensii* 51329 might damage the epithelium by attaching to enterocytes and causing enterocyte apoptosis. The fact that *C. muytjensii* 51329 significantly increases NEC scores satisfies the second Koch postulate -- that introduction of a cultured microbe into a healthy subject should cause the disease. The intestinal titers of *C. muytjensii* 51329 increased more than 5 logs in 3 days following introduction of this strain to neonatal rats. Thus, the same strain was recovered from NEC rats following the introduction of *C. muytjensii* 51329, which satisfies the third Koch postulate. These data also demonstrate that *C. muytjensii* 51329 is capable of colonizing the GI tract of the neonate [@bb0360].

To determine whether the pathogenic properties of *C. muytjensii* are strain-specific, multiple independent clinical, environmental, and food origin isolates of this species were examined for their ability to bind to intestinal epithelial cells. The strains that efficiently bound to enterocytes, caused enterocyte apoptosis and disrupted the epithelial barrier were exclusively clinical isolates. Therefore, the pathogenic affinity of *C. muytjensii* for the intestinal epithelium is strain-specific rather than species-specific [@bb0365]. This finding may shed some light on the limited success of microbiome studies in NEC. Most of these studies identified bacteria by species, whereas virulence within a species may be strain-specific. Detailed whole genome analysis and microbiological studies may be necessary to distinguish between pathogenic and nonpathogenic strains of the same species.

9. Conclusions and perspective {#s0045}
==============================

The pathogenesis of NEC is still incompletely understood. Nitric oxide and its oxidation intermediates play a prominent role in the epithelial barrier damage by increasing enterocyte apoptosis, decreasing enterocyte proliferation and impairing enterocyte migration. iNOS, the enzyme responsible for the dramatic elevation of NO during intestinal inflammation, is regulated by inflammatory factors and pathogens via a complex network of signaling cascades including Toll-like and cytokine receptors, intracellular signaling mediators, and transcription factors. Although much is known about iNOS gene regulation in mouse macrophages, this information may be of limited value for understanding iNOS regulatory networks in other cell types and species. Particularly, iNOS regulation in the intestine remains largely unknown, and efforts in this direction are necessary for the design of iNOS-targeted NEC therapies.

The key role of bacteria in the pathogenesis of NEC is universally recognized. However, whether NEC is caused by specific bacteria remains a matter of debate. Early intestinal microbiomes are highly diverse, simple, and fluid, as opposed to adult populations, which are relatively uniform, complex, and stable. A broad range of bacteria may act as predominant first colonizers. Total microbial load and species composition in early microbiomes may be, to a large extent, a matter of chance. Some of the first colonizers may act as opportunistic pathogens, while others may be innocuous or even protective. Proteobacteria, a group of Gram-negative bacteria that includes such potentially pathogenic genera as *Escherichia*, *Salmonella*, *Shigella*, *Klebsiella*, and *Pseudomonas*, are often found in NEC patients. Studies in *C. muytjensii* clearly demonstrated that the ability to act as an NEC pathogen is the property of individual strains rather than a species as a whole. Understanding the roles of bacteria in the pathogenesis of NEC will require microbiological experiments and genome-wide analysis of virulence.
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